NOVT Novanta Inc
Company Analysis
Latest News
🟢 Novanta is trading 4.84% up in pre-market despite broader market weakness
Novanta is trading 4.84% up at $153.29 after closing at $146.22 on August 31, 2026; no fresh company-specific announcement dated August 31 or September 1 was...
🟢 Novanta is trading 4.11% up today; catalyst remains uncertain
Novanta is trading at $145.38, up +4.11%, with no clearly identified company-specific catalyst on August 26, 2026. - The latest company-specific developments...
🟢 Novanta is trading 5.95% up in pre-market
Novanta is trading at $147.96, up 5.95% in pre-market, though the immediate catalyst remains uncertain. - No new company-specific announcement or overnight...
🟢 Novanta is trading 5.1% up in after-hours trading; catalyst remains unclear
Novanta is trading 5.1% up at $146.63 after closing at $139.48 on August 24, 2026; no verified catalyst explains the after-hours rebound. - No verified...
🔴 Novanta is trading 4.4% down today amid broader technology selling and higher bond yields
Novanta is trading 4.4% down now at $138.88, amid broader pressure on growth-heavy technology stocks. - The shares fell from the August 21 close of $145.24. -...
🟢 Novanta is trading 5% up in after-hours trading amid broader risk appetite
Novanta is trading at $152.30, up +4.86% after-hours, with broader risk appetite likely contributing to the move. - No new August 21, 2026 company-specific...
🔴 Novanta is trading 5.3% down
Novanta is trading at $148.79, down 5.3% from a comparison close of $157.11 during regular trading. This is a price-action follow-up, so a separate catalyst...
🔴 Novanta is trading 4.4% down today despite broader market gains
Novanta is trading at $150.12, down 4.40%, as the broader market rises. • No clear company-specific announcement or catalyst was identified for August 19,...
🔴 Novanta is trading 4.23% down today; no clear catalyst identified
Novanta is trading at $150.47 (-4.23%), with no clear catalyst identified. - No new company-specific announcement explaining the August 19, 2026 decline was...
🔴 Novanta is trading 4.7% down today as technology stocks lead market pullback
Novanta is trading 4.7% down now at $160.80 as technology stocks lead a broader market pullback. - No clearly identified company-specific announcement...
🟢 Novanta is trading 9.64% up in pre-market; no clear catalyst identified
Novanta is trading 9.64% up at $185.01 in pre-market, with no clearly dated August 18, 2026 company announcement or reliable report directly explaining the...
🟢 Novanta is trading 5% up in pre-market; immediate catalyst remains unclear
Novanta is trading 4.94% up at $175.51, although no new company-specific announcement was identified for August 14, 2026. - August 5 second-quarter results...
🟢 Novanta is trading 5% up in pre-market after Q2 results and raised 2026 revenue guidance
Novanta is trading 5% up at $172.36 as investors react to its August 5 second-quarter results and upgraded outlook. - Revenue was $265.8 million and adjusted...
🟢 Novanta is trading 8.2% up in pre-market after Q2 results and raised full-year revenue guidance
Novanta is trading 8.2% up at $180.01 after investors continued reacting to its August 5 second-quarter earnings release. - Revenue reached $265.8 million,...
Novanta's Blowout Quarter and $1.2 Billion Medical Bet: Can the Stock Sustain a 13% Single-Day Rally?
Shares of Novanta surged 12.9% to $172.89 after the precision-technology supplier posted second-quarter results that beat Wall Street across the board — and...
Novanta's Blowout Quarter and $1.2 Billion Medical Bet: Can the Stock Sustain a 13% Single-Day Rally?
Shares of Novanta surged 12.9% to $172.89 after the precision-technology supplier posted second-quarter results that beat Wall Street across the board — and...
Novanta's Blowout Quarter and $1.2 Billion Medical Bet: Can the Stock Sustain a 13% Single-Day Rally?
Shares of Novanta surged 12.9% to $172.89 after the precision-technology supplier posted second-quarter results that beat Wall Street across the board — and...
Novanta's Blowout Quarter and $1.2 Billion Medical Bet: Can the Stock Sustain a 13% Single-Day Rally?
Shares of Novanta surged 12.9% to $172.89 after the precision-technology supplier posted second-quarter results that beat Wall Street across the board — and...
🟢 Novanta is trading 4.08% up today after Q2 earnings beat and stronger full-year outlook
Novanta is trading 4.08% up at $169.99 after investors continued rewarding its August 5 earnings beat and stronger outlook. - Second-quarter revenue reached...
🟢 Novanta is trading 4.05% up today in pre-market on strong Q2 results and raised 2026 outlook
Novanta is trading 4.05% up now at $169.93 after strong second-quarter results and a raised 2026 outlook. - Revenue reached $265.8 million, adjusted EPS was...